How Hallucinatory A.I. Helps Science Dream Up Big Breakthroughs
Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.
Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.
A new evolutionary analysis of butterflies finds “false heads” arose from the coalescence of multiple traits
An Alzheimer’s disease–associated mutation in the kinase PKCη concentrates its activity at the Golgi.
Scientists, ethicists, and officials worry the OpenAI-sponsored contest sidesteps archaeological norms
This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.
Over 6,000 restrings, tiny variances in string tension and customized logos: How Wimbledon gets its stars’ rackets ready for play.
A newly developed generative AI model is helping researchers explore protein dynamics with increased speed.
AI guidance is enabling robots to perform medical needle-based procedures with greater safety and accuracy.
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.
Trump executive order leads to pauses on U.S.-funded research into TB, influenza, COVID-19, and other diseases, dismaying some scientists
Sundar Subramanian, a partner at PricewaterhouseCoopers (PwC) consulting affiliate Strategy&, has joined population health management company Zyter|TruCare as its newest CEO, Fierce Healthcare | AI…